Min Chen1, Mingjue Zhao1, Caroline G Lee2,3,4, Samuel S Chong1,5,6. 1. Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 2. Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 3. Division of Medical Sciences, National Cancer Center, Singapore, Singapore. 4. Duke-NUS Graduate Medical School, Singapore, Singapore. 5. Preimplantation Genetic Diagnosis Center, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore, Singapore. 6. Molecular Diagnosis Center and Clinical Cytogenetics Service, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore.
Abstract
PURPOSE: To develop a single-tube polymerase chain reaction (PCR) panel of highly polymorphic markers for preimplantation genetic diagnosis (PGD) of fragile X syndrome (FXS). METHODS: An in silico search was performed to identify all markers within 1 Mb flanking the FMR1 gene. Selected markers were optimized into a single-tube PCR panel and their polymorphism indices were determined from 272 female samples from three populations. The single-tube assay was also validated on 30 single cells to evaluate its applicability to FXS PGD. RESULTS: Thirteen markers with potentially high polymorphism information content (PIC) and heterozygosity values were selected and optimized into a single-tube PCR panel together with AMELX/Y for gender determination. Analysis of 272 female samples confirmed the high polymorphism (PIC > 0.5) of most markers, with expected and observed heterozygosities ranging from 0.31 to 0.87. More than 99% of individuals were heterozygous for at least three markers, with 95.8% of individuals heterozygous for at least two markers on either side of the FMR1 CGG repeat. CONCLUSION: The tetradecaplex marker assay can be performed directly on single cells or after whole-genome amplification, thus supporting its use in FXS PGD either as a standalone linkage-based assay or as a complement to FMR1 mutation detection.Genet Med 18 9, 869-875.
PURPOSE: To develop a single-tube polymerase chain reaction (PCR) panel of highly polymorphic markers for preimplantation genetic diagnosis (PGD) of fragile X syndrome (FXS). METHODS: An in silico search was performed to identify all markers within 1 Mb flanking the FMR1 gene. Selected markers were optimized into a single-tube PCR panel and their polymorphism indices were determined from 272 female samples from three populations. The single-tube assay was also validated on 30 single cells to evaluate its applicability to FXS PGD. RESULTS: Thirteen markers with potentially high polymorphism information content (PIC) and heterozygosity values were selected and optimized into a single-tube PCR panel together with AMELX/Y for gender determination. Analysis of 272 female samples confirmed the high polymorphism (PIC > 0.5) of most markers, with expected and observed heterozygosities ranging from 0.31 to 0.87. More than 99% of individuals were heterozygous for at least three markers, with 95.8% of individuals heterozygous for at least two markers on either side of the FMR1 CGG repeat. CONCLUSION: The tetradecaplex marker assay can be performed directly on single cells or after whole-genome amplification, thus supporting its use in FXS PGD either as a standalone linkage-based assay or as a complement to FMR1 mutation detection.Genet Med 18 9, 869-875.
Authors: Peter Platteau; Karen Sermon; Sara Seneca; André Van Steirteghem; Paul Devroey; Inge Liebaers Journal: Hum Reprod Date: 2002-11 Impact factor: 6.918
Authors: P Burlet; N Frydman; N Gigarel; V Kerbrat; G Tachdjian; E Feyereisen; J-P Bonnefont; R Frydman; A Munnich; J Steffann Journal: Mol Hum Reprod Date: 2006-08-08 Impact factor: 4.025
Authors: K Sermon; S Seneca; M De Rycke; V Goossens; H Van de Velde; A De Vos; P Platteau; W Lissens; A Van Steirteghem; I Liebaers Journal: Mol Cell Endocrinol Date: 2001-10-22 Impact factor: 4.102
Authors: Joyce C Harper; Dagan Wells; Wirawit Piyamongkol; Patrick Abou-Sleiman; Angela Apessos; Antonis Ioulianos; Mary Davis; Alpesh Doshi; Paul Serhal; Massimo Ranieri; Charles Rodeck; Joy D A Delhanty Journal: Prenat Diagn Date: 2002-06 Impact factor: 3.050
Authors: Indhu-Shree Rajan-Babu; Mulias Lian; Felicia S H Cheah; Min Chen; Arnold S C Tan; Ethiraj B Prasath; Seong Feei Loh; Samuel S Chong Journal: Expert Rev Mol Med Date: 2017-07-19 Impact factor: 5.600